LeapZipBlog: Mike Williams's blog: Cholera Vaccine Market: Surging Demand Motivated by Modernization Set to Uphold Higher Revenue

Cholera Vaccine Market: Surging Demand Motivated by Modernization Set to Uphold Higher Revenue

December 6, 2019 by Mike Williams  

The global cholera vaccine market generated $65 million in 2017, and is projected to reach $207 million by 2025, growing at a CAGR of 15.6% from 2018 to 2025.

Cholera is an acute intestinal infection that causes rapidly dehydrating diarrheal disease, which is caused by toxigenic serogroups of the bacterium Vibrio cholera. The disease is closely associated with poverty, poor sanitation, and lack of clean drinking water. Historically, devastating outbreaks of cholera resulted in millions of cases and hundreds of thousands of deaths. Currently, cholera remains an important public health problem in many countries, occurring as an endemic disease in some regions and causing major epidemics in some low- and middle-income countries (LMICs). The vaccine is used to control cholera and is mainly recommended for travelers and the people living in cholera-affected region. 

Request for Sample Report @ https://www.factomarketinsights.com/sample/242

There is an increase in the demand for cholera vaccine due to lack of proper sanitation & consumption of contaminated food and growth in the awareness about cholera preventive care. In addition, development of novel approaches for new cholera vaccine further drive the market growth. However, risk of adverse effects and the time taken for the regulatory approval is projected to impede the market growth. On the contrary, high growth opportunities in untapped markets are expected to offer significant profitable opportunities for the market players.

The global cholera vaccine market is segmented based on product, end user, and region. Based on product, the market is segmented into Dukoral, Shanchol, Vaxchora, Euvichol & Euvichol-Plus, and others. Depending on end user, the market is categorized into hospitals & clinics, research & academic laboratories, and others. Based on region, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits For Cholera Vaccine Market:

This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2025, which assists to identify the prevailing market opportunities. 

An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.

A comprehensive analysis of the factors that drive and restrain the growth of the global cholera vaccine market is provided.

An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

Download Complete Research report with TOC @ https://www.factomarketinsights.com/report/242/cholera-vaccine-market-amr

Cholera Vaccine Key Market Segments:

By Product

Euvichol & Euvichol-Plus

By End User

Hospitals & Clinics
Research & Academic Laboratories

By Region

North America
Rest of Europe
Rest of Asia-Pacific
Rest of LAMEA

Get Reprot Research Methodology @ https://www.factomarketinsights.com/method/242

Key Market Players

Valneva SE
Emergent BioSolutions, Inc. (PaxVax, Inc.)
Astellas Pharma, Inc.
Sanofi (Shantha Biotechnics Private Limited)
Eubiologics Co., Ltd.
Johnson & Johnson (Crucell)
Celldex Therapeutics, Inc.
The other players in the value chain include (profiles not included in the report):
Merck & Co., Inc.
GlaxoSmithKline plc."

 About Us

Facto market insights is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.

Our in-house research experts have a wealth of knowledge in their respective domains. With Facto Market Research, you always have the choice of getting customized report free of cost (upto 10%). Our support team will help you customize the report and scope as per your business needs. This ensures that you are making the right purchase decision.

Contact Us

United States

150 State St.
Suite 301
Albany, NY 12207
United States
Email: info@factomarketinsights.com

Tel: +1 518-300-1215